A

amgen-non-gaap-eps-of-$529-beats-by-$053,-revenue-of-$9.9b-beats-by-$440m

A AMGN Biotechnology Uncategorized

Amgen Non-GAAP EPS of $5.29 beats by $0.53, revenue of $9.9B beats by $440M

Feb 3, 2026

Amgen press release (AMGN): Q4 Non-GAAP EPS of $5.29 beats by $0.53. Revenue of $9.9B...

A Biotechnology REGN Uncategorized

Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY26 outlook

Jan 30, 2026

clene-announces-registered-direct-offering-of-over-$28m

A B Biotechnology CLNN Uncategorized

Clene announces registered direct offering of over $28M

Jan 9, 2026

On the Move Comments Clene (CLNN) on Friday announced a registered direct offering priced above...